ANALYTICAL METHOD TO EVALUATE, IN VITRO, THE INTESTINAL ABSORPTION OF THE ACETAZOLAMIDE BY HPLC
ANA LUIZA R. SOUZA1; JULIA2; GLADYS2; MARCELA2; MARCO VINICIUS CHAUD3; MARIA PALMIRA D. GREMIÃO1
1 Faculdade de ciências Farmacêuticas; 2Faculdad de Ciências Químicas – Universidad Nacional de Córdoba; 3UNISO
INTRODUCTION: The acetazolamide (ACZ) is a potent and reversible carbonic anhydrase inhibitor, effective in the control of fluid secretion, e. g., glaucomas, in the treatment of certain convulsive disorders, e. g., epilepsy, and in the promotion of diuresis in instances of abnormal fluid retention. It is poorly water- and lipid-soluble drug. Despite this, it is rapidly and almost completely absorbed from the gastrointestinal tract. OBJECTIVE: In this study, a simple HPLC method was developed, in order to monitor the concentration of ACZ in TC-199 buffer in vitro, in the rat everted gut sac absorption model. METHODOLOGY: Varian HPLC system was used for purpose of analysis in the study and it consisted of a ProStar/Dynamax 210/215 Solvent Delivery Module, ProStar 330 UV-VIS PDA Spectrophotometric Detector, and a Rheodine VS 7125, injection valve with a 100μL loop. The drug was analyzed using 250 x 4.6mm C18 (Varian - Chromsep) column. The isocratic mobile phase was a mixture of methanol: water pH 4.0 at 10:90 (v/v). The flow-rate was 1 mL/min and the quantitative determination was carried out at 265 nm, at